Skip to content
10-K

Annual Report

Puramed Bioscience Inc.

0001354488-14-005105

← back to feed
Filed
Oct 14, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Oct 7, 2014 70.66M sh
Capex FY 2014 · Jun 30, 2014 $3.89K
Capex FY 2014 · Jun 30, 2013 $0
Operating Cash Flow FY 2014 · Jun 30, 2014 −$797.57K
Operating Cash Flow FY 2014 · Jun 30, 2013 −$1.33M
Short Term Debt FY 2014 · Jun 30, 2014 $320.57K
Short Term Debt FY 2014 · Jun 30, 2013 $454.03K
Stockholders Equity FY 2014 · Jun 30, 2014 −$5.14M
Stockholders Equity restated FY 2014 · Jun 30, 2013 −$2.77M
Stockholders Equity FY 2014 · Jun 30, 2012 −$1.07M
Current Liabilities FY 2014 · Jun 30, 2014 $5.32M
Current Liabilities FY 2014 · Jun 30, 2013 $3.17M
Current Assets FY 2014 · Jun 30, 2014 $71.08K
Current Assets FY 2014 · Jun 30, 2013 $326.24K
Total Assets FY 2014 · Jun 30, 2014 $186.34K
Total Assets FY 2014 · Jun 30, 2013 $476.35K
Sga Expense FY 2014 · Jun 30, 2014 $288.41K
Sga Expense FY 2014 · Jun 30, 2013 $195.21K
Rd Expense FY 2014 · Jun 30, 2014 $0
Rd Expense FY 2014 · Jun 30, 2013 $75.06K
Net Income FY 2014 · Jun 30, 2014 −$5.23M
Net Income FY 2014 · Jun 30, 2013 −$2.56M
Operating Income FY 2014 · Jun 30, 2014 −$2.7M
Operating Income FY 2014 · Jun 30, 2013 −$2.01M
Gross Profit FY 2014 · Jun 30, 2014 −$443.86K
Gross Profit FY 2014 · Jun 30, 2013 −$52.53K
Cost Of Revenue FY 2014 · Jun 30, 2014 $443.86K
Cost Of Revenue FY 2014 · Jun 30, 2013 $95.33K
Revenue FY 2014 · Jun 30, 2014 $0
Revenue FY 2014 · Jun 30, 2013 $42.81K